Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tyree Kiser PharmD, FCCP, FCCM, BCPS

Tyree H. Kiser PharmD, FCCP, FCCM, BCPS

Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus; Clinical Pharmacy Specialist – Critical Care, University of Colorado Hospital, Aurora, Colorado

Dr. Ty Kiser is a Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. He is a Clinical Pharmacy Specialist in the Medical Intensive Care Unit at the University of Colorado Hospital. Dr. Kiser received his Pharm.D. at the University of North Carolina. He completed a pharmacy practice residency at Johns Hopkins Hospital and a Critical Care Residency and Critical Care/Infectious Diseases Fellowship at the University of Colorado. Dr. Kiser served as the chair of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology section and as chair of the American College of Clinical Pharmacy (ACCP) critical care practice and research network. He is currently on the board of regents for ACCP. Dr. Kiser’s research has focused on optimizing the pharmacokinetics and pharmacodynamics of pharmacologic agents in critically ill patients with organ dysfunction and has resulted in over 90 peer reviewed publications.  

Disclosures

Dr. Kiser disclosues the following: Investigator initiated grant funding from Astellas Pharma and Allergan.